E2F3 and urinary bladder carcinoma: In conclusion, we demonstrated that QKI‐6 down‐regulation in bladder cancer tissues and cells promoted tumour cell malignant behaviours by down‐regulating E2F3 and NF‐κB signalling pathways (Figure 9).